Patient Demographics: AGE: 67 year old Gender: Female Cardiac risk Factors: Hypertension, Diabetes, hypercholesterolemia Clinical Presentation: NSTEMI.

Slides:



Advertisements
Similar presentations
MAIN-COMPARE Study – Disclosure Information
Advertisements

Call for CASES Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department:
MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.
LAD/D1 bifurcation lesion. Crush technique. 35yr old male.
Bifurcation LAD/D2 lesion. Provisional T stenting.
Multivessel PCI procedure complicated with fracture of the wire Marcin D ę binski, MD Head: Pawel E. Buszman, MD, FACC University Hospital of Silesia,
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
ARTS I & II Keith D Dawkins Southampton University Hospital.
CPORT- E Trial Randomized trial comparing medical, economic and quality of life outcomes of non-primary PCI at hospitals with and without on-site cardiac.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
Call for CASES One Stage Coronary And Peripheral Intervention (OCAPI) in a patient with accelerated diffuse atherosclerosis after chest irradiation. One.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
PCI For MVD: Complete vs Partial Revascularization --Partial More Realistic in Most Patients Yuejin Yang MD, PhD, FACC Cardiovascular Institute and Fu-Wai.
Subacute Occlusion at distal Edge of Stent Beijing Anzhen Hospital Capital Medical University Wu, Xiaofan.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
ARMYDA-5 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study Prospective, multicenter, randomized trial investigating influence.
IVUS evaluation TAP technology for unprotected left main bifurcation lesions interventional therapy Yong-Sheng Ke. MD Department of Cardiology, Yijishan.
Professor Martin T Rothman Director Cardiac Research & Development Barts & The London NHS Trust London, England Professor Martin T Rothman Director Cardiac.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
“Randomized Comparison between Sirolimus (Cypher)/Sirolimus-analogous (Xience; Promus) vs. Paclitaxel (Taxus vs.Costar) Eluting Stents in Coronary Lesions:
Allen Jeremias, Neal Kleiman, Deborah Nassif, Wen-Hua Hsieh, Michael Pencina, Kelly Maresh, Manish Parikh, Donald Cutlip, Ron Waksman, Steven Goldberg,
Gender Differences in Long-Term Outcomes Following PCI of Patients with Non-ST Elevation ACS: Results from the ACUITY Trial Alexandra J. Lansky on behalf.
Strategies to Improve Inadequate Guide Catheter Support John S Douglas Jr MD S Tanveer Rab MD Emory University School of Medicine Atlanta Georgia Sunday.
Multivessel Coronary Artery Disease
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Hybrid Off-Pump Revascularization; Early & Midterm Results 서울대학교병원 흉부외과 황 호영, 조 광리, 김 기봉.
RAVEL 4 YEAR FOLLOW-UP - Cordis Cardiology / Cardialysis – Euro-PCR – Sousa – 24 May 2005 RAVEL A RAndomised, double-blind study with the Sirolimus-eluting.
The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Treatment of Protected and Unprotected.
The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxide-coated Cobalt Chromium stents in patients with de novo coronary artery.
Adel Gamal, MD and Mohamed Saber, Msc
Ospedale San Raffaele, Milan, Italy
Successful transdradial removal of a dislodged coronary stent
Latvian Centre of Cardiology real-life registry
Strategies to Improve Inadequate Guide Catheter Support
Interesting Case Presentation
Clinical Presentation
Tubular LMS stenosis. LCx ostial stenosis
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
Acute and Mid-Term Outcomes of Coronary Stent Implantation for the Treatment of Unprotected Left Main Coronary Artery Disease Dr mahmoud ebrahimi Dr hosein.
Meruzhan Saghatelyan, MD, Interventional cardiologist
Coronary bifurcation wide-neck aneurysm successfully treated by provisional Y-stent-assisted coil embolization Gregory A. Sgueglia, MD, PhD Interventional.
Intra-Aortic Balloon Pump For Complex Calcified Left-Main Bifurcation Lesion Supawat Ratanapo, MD Medical College of Georgia, Augusta University.
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Fractional Flow Reserve Workshop
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Five-Year Cumulative Rates of Clinical Events after Cypher™ Stent Implantation: Insights from a Patient-Level Pooled Analysis of Four Randomized Trials.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Presented at TCT 2006.
Impact of Diabetes Mellitus on Long-term Outcomes in the
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
Atlantic Cardiovascular Patient Outcomes Research Team
Effect of Additional Temporary Glycoprotein IIb-IIIa Receptor Inhibition on Troponin Release in Elective Percutaneous Coronary Interventions After Pretreatment.
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
Presentation transcript:

Patient Demographics: AGE: 67 year old Gender: Female Cardiac risk Factors: Hypertension, Diabetes, hypercholesterolemia Clinical Presentation: NSTEMI Cardiac Catheterization Findings: LM: Calcified distal 80%-90% stenosis. LAD: Ostial 90%, Calcified vessel.mid 80% stenosis. LCX: Dominant. OM2 Proximal 70% stenosis. RCA:Small vessel. Distal 80% stenosis. LV function: Normal wall motion, EF: ~50% R. Castillo, SUNY Downstate Medical Center Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). SCAI C3 Summit Chicago May 12-13, 2006

Treatment recommendation: CABG -> Patient refused. Patient stabilized and discharged home for elective PCI. PCI strategy: Direct stenting of mid LAD and distal LM-Ostial LAD with DES at high pressure. Provisional PCI of proximal LCX if needed. Tirofiban Bolus to achieve PAU 200 sec. Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). SCAI C3 Summit Chicago May 12-13, 2006 R. Castillo, SUNY Downstate Medical Center

SCAI C3 Summit Chicago May 12-13, 2006 Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). R. Castillo, SUNY Downstate Medical Center Baseline AP Cranial and AP Caudal: LM and mid LAD calcified stenosis

SCAI C3 Summit Chicago May 12-13, 2006 Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). R. Castillo, SUNY Downstate Medical Center AP Cranial Cypher 3.0x8, 26atms

SCAI C3 Summit Chicago May 12-13, 2006 Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). R. Castillo, SUNY Downstate Medical Center AP Caudal Cypher 3.5x18, 26atms

SCAI C3 Summit Chicago May 12-13, 2006 Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). R. Castillo, SUNY Downstate Medical Center Quantum maverick 4.0x12, 18 atms x 2 AP caudal

SCAI C3 Summit Chicago May 12-13, 2006 Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). R. Castillo, SUNY Downstate Medical Center Final Result AP caudal RAO Cranial

Brief Case Summary: 67 year old female with calcified severe LM and LAD stenosis treated with direct, very high pressure deployment, Cypher DEStents. Allowing for very good dilatation and apposition of the stent into the vessel wall. Take Home Points High pressure deployment of stent assure good apposition and expansion of the stent. Short and simple approach to lesion reduce complications. LM stenting is safe and feasible procedure. Good anticoagulation and antithrombotic tto is crucial. R. Castillo, SUNY Downstate Medical Center Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms). SCAI C3 Summit Chicago May 12-13, 2006

REFERENCES: Matthew J. Price, Ecaterina Cristea, Neil Sawhney, John A. Kao, Jeffrey W. Moses, Martin B. Leon, Ricardo A. Costa, Alexadra J. Lansky and Paul S. Teirstein. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol Feb 21;47(4):871-7 Alaide Chieffo, Goran Stankovic, Erminio Bonizzoni, Eleftheria Tsagalou, Ioannis Iakovou, Matteo Montorfano, Flavio Airoldi, Iassen Michev, Massimo Giuseppe Sangiorgi, Mauro Carlino, Giancarlo Vitrella and Antonio Colombo. Early and Mid- Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main. Circulation Feb 15;111(6):791-5 Poludasu S. and Jonathan D. Marmur et al. “A single Center Study of Bolus only glycoprotein IIb/IIIa Inhibitors (Tirofiban) during PCI”. SUNY-Downstate. Annual Research day, April Case Title: Unprotected Left main intervention using a DES at very high pressure (26 Atms).